-
. We ultimately aim to improve outcomes for children with cancer, with a particular focus on neuroblastoma and other high-risk pediatric solid tumors. Our hybrid wet-dry lab has led publications in
-
The Geeleher Lab tightly integrates wet-bench and computational approaches to improve outcomes for children with cancer, with a particular focus on neuroblastoma and other high-risk pediatric solid
-
transcription platforms. Work will involve solid-phase transcription, preparation of regionally modified mRNAs, and functional characterization of modified transcripts. A background in RNA biochemistry or nucleic
-
A postdoctoral position is available in the laboratory of Samuel W. Brady. The lab focuses on identifying and therapeutically targeting key dependencies in pediatric solid tumors (Banu et al